The ABC multidrug transporter LmrA of Lactococcus lactis consists of 6 putative transmembrane segments (TMSs) and a nucleotide binding domain. LmrA functions as a homodimer in which the two membrane domains form the solute translocation path across the membrane. To obtain structural information of LmrA a cysteine scanning accessibility approach was used. Cysteines were introduced in the cysteine-less wild-type LmrA in each hydrophilic loop and in TMS 6, and each membrane-embedded aromatic residue was mutated to cysteine. Out of the 41 constructed single cysteine mutants, only one mutant, L301C, was not expressed. Most single-cysteine mutants were capable of drug transport and only three mutants, F37C, M299C and N300C, were inactive, indicating that none of the aromatic residues in the transmembrane regions of LmrA is crucial for substrate binding or transport.
SUMMARY
The ABC multidrug transporter LmrA of Lactococcus lactis consists of 6 putative transmembrane segments (TMSs) and a nucleotide binding domain. LmrA functions as a homodimer in which the two membrane domains form the solute translocation path across the membrane. To obtain structural information of LmrA a cysteine scanning accessibility approach was used. Cysteines were introduced in the cysteine-less wild-type LmrA in each hydrophilic loop and in TMS 6, and each membrane-embedded aromatic residue was mutated to cysteine. Out of the 41 constructed single cysteine mutants, only one mutant, L301C, was not expressed. Most single-cysteine mutants were capable of drug transport and only three mutants, F37C, M299C and N300C, were inactive, indicating that none of the aromatic residues in the transmembrane regions of LmrA is crucial for substrate binding or transport.
Modification of the active mutants with N-ethylmaleimide blocked the transport activity in 5 mutants (S132C, L174C, S206C, S234C, and L292C). All cysteine residues in external and internal loops were accessible to fluorescein maleimide. The labeling experiments also showed that this thiol reagent can not cross the membrane under the conditions used, and confirmed the presence of 6 TMSs in each monomeric half of the transporter. Surprisingly, several single cysteines in the predicted TMSs could also be labeled by the bulky fluorescein maleimide molecule, suggesting unrestricted accessibility via an aqueous pathway. The periodicity of fluorescein maleimide accessibility of residues 291 to 308 in TMS 6 showed that this membrane spanning α-helix has one face of the helix exposed to an aqueous cavity along its full length. This finding, together with the solvent accessibility of 11 out of 15 membrane-embedded aromatic residues, indicates that the transmembrane domains of the LmrA transporter form, under non-energized conditions, an aqueous chamber within the membrane, which is open to the intracellular milieu.
INTRODUCTION
Resistance of cells to multiple structurally unrelated drugs and/or antibiotics (termed multidrug resistance) causes serious problems in the treatment of cancers and infectious diseases (1, 2) . Multidrug resistance can be conferred by a number of transporters (MDRs 1 )
that pump drugs out of cells (for recent reviews, see 3, 4) . Certain multidrug transporters, such as the Lactococcus lactis protein LmrA, can transport an extreme diversity of structurally dissimilar drug molecules (reviewed in 5). LmrA belongs to a superfamily of transporters that contain an ATP binding cassette (ABC) (6) . It shares significant sequence similarity with members of the P-glycoprotein subfamily of ABC transporters, most notably the human multidrug resistance P-glycoprotein (6) . This human P-glycoprotein, which is also called MDR1, plays a crucial role in the resistance of cancer cells against cytotoxic agents used in chemotherapy (2) . Bacterial LmrA can functionally complement P-glycoprotein in human lung fibroblast cells, and both proteins have a very similar drug and modulator specificity (7) .
This remarkable conservation of function between these two ABC-type multidrug transporters implies a common overall structure and transport mechanism (8 Most ABC transporters recognize and transport highly hydrophilic substrates, including sugars and inorganic ions, most likely via an aqueous pathway. An example is the cystic fibrosis transmembrane regulator (CFTR), which unquestionably forms an aqueous pathway across the membrane through which chloride ions travel. However, multidrug transporters such as LmrA and P-glycoprotein translocate highly hydrophobic substrates and transport might occur via a hydrophobic, lipid-filled pathway. LmrA and P-glycoprotein have been shown to function as "hydrophobic vacuum cleaners" by extruding drug molecules from the inner leaflet of the lipid bilayer directly into the (external) aqueous phase (10, 11) . These and other studies suggest that the translocation pathway has an opening to the extracellular milieu, and may be accessible from the membrane rather than from the internal aqueous phase.
In this study we used a cysteine scanning accessibility approach to obtain information about the structural properties of LmrA. Cysteines were introduced in the cysteine-less wildtype LmrA in each hydrophilic loop and in TMS 6, and each membrane-embedded aromatic residue was mutated to cysteine. The accessibility was studied of these cysteines to fluorescein maleimide, a well characterized sulfhydryl reagent that reacts with cysteines that are located in polar environments, but not with those in nonpolar environments,. The accessibilities of cysteine replacements of all amino acid residues in TMS 6 were studied in detail as the corresponding TMSs in P-glycoprotein (TMSs 6 and 12) have been strongly implicated in substrate binding (e.g. 12, 13). The membrane-embedded aromatic residues were chosen for study since aromatic rings can contribute to binding of aromatic cationic substrates through both aromatic-aromatic and π-cation interactions (14) . In addition, aromatic residues lining an internal channel may provide a surface which is sterically compatible to the geometry of the drug and thus may promote the passage of a variety of ringcontaining LmrA substrates (14) . Taken as a whole, the results suggest the presence of a water-filled chamber, which in the non-energized form of LmrA is open to the intracellular environment, within the membrane-embedded domain of this transporter for hydrophobic molecules.
EXPERIMENTAL PROCEDURES

Bacterial strains, plasmids, and growth conditions
Lactococcus lactis NZ9000 (lmrA 
Site-directed mutagenesis
Techniques for restriction enzyme digestion, ligation, transformation, and other standard molecular biology manipulations were based on methods described by Sambrook et al. (17) . The overlap extension polymerase chain reaction (18) was used to introduce mutations in the lmrA gene on plasmid pNHLmrA, which encodes LmrA with an aminoterminal His-tag consisting of six adjacent histidines (19) . All polymerase chain reactionamplified DNA fragments were sequenced to ensure that only the intended changes have been introduced. DNA sequencing was performed at the BioMedical Technology Centre (Groningen, The Netherlands).
Preparation of membrane vesicles
Membrane vesicles with an inside-out orientation were prepared by passage through a french pressure cell as described before (19 polyacrylamide. The gels were stained with Coomassie brilliant blue.
Transport assays
Inside-out membrane vesicles were diluted to a protein concentration of 0.5 mg/ml in 2 ml of 50 mM (K)Hepes, pH 7.4, supplemented with 2 mM MgSO 4 , 8.5 mM NaCl, 0.1 mg/ml creatine kinase, and 5 mM phosphocreatine. After 1 min incubation at 30ºC, 2 µM 2- Subsequently, 2 mM Mg-ATP was added, and Hoechst 33342 fluorescence was followed as a function of time. Fluorescence was monitored with a Perkin-Elmer LS 50B fluorometer, using excitation and emission wavelengths of 355 and 457 nm, respectively, and slit widths of 3 nm each.
To test the effect of thiol-reagents on transport, inside-out membrane vesicles (1 mg of total protein) were incubated for 10 min at 30ºC with 1 mM N-ethylmaleimide (NEM; Sigma) or 1 mM 2-aminoethyl methanethiosulfonate hydrobromide (MTSEA; Anatrace, Ohio).
Immediately after labeling, Hoechst 33342 transport assays were performed with these membrane vesicles.
Labeling of membrane vesicles with maleimides
Unless stated otherwise, membrane vesicles (1 mg of total protein in 500 µl of 50 mM 
RESULTS
Construction, expression, and activity of single cysteine mutants
Wild-type LmrA is devoid of native cysteine residues, and, therefore, is excellently suited for a cysteine-scanning mutagenesis approach. In this study, site-directed mutagenesis was used to construct a set of 41 single cysteine mutants. The codon for each residue in TMS 6 (residues 291-312) was mutated to that of cysteine, as well as the codon for each membraneembedded aromatic residue ( Fig. 1 ). In addition, at least one single cysteine was introduced in each hydrophilic loop of LmrA ( At most of the positions of membrane-embedded aromatic residues, cysteine mutations were well tolerated by the transporter, resulting in similar or slighty reduced transport activities when compared to the wild-type protein ( Table 1 ). The proteinasesensitive mutant F37C was found to be inactive. Cysteine mutations in the loop regions of the transporter were all well tolerated (Table 1) . Mutants S65C and T109C displayed wild-type transport activities, whereas mutants S132C, L174C, S206C, S234C, and S287C had slightly reduced transport activities. In contrast, several cysteine mutants in TMS 6 exhibited strongly reduced transport activities (Table 1 ). This might be explained, at least in part, by the low expression levels of these mutants ( Fig. 2A) . Two mutants in TMS 6, M299C and N300C, displayed no measurable transport activities.
We have shown previously that verapamil is an inhibitor of LmrA-mediated Hoechst 33342 transport (19) . The ability of verapamil to inhibit transport by the single cysteine mutants was examined (Table 1) . Verapamil (50 µM) inhibited Hoechst 33342 transport by wild-type LmrA and most mutants by more than 50%. In contrast, verapamil had only minor effects on Hoechst 33342 transport by mutants L298C, G303C, T307C, and A309C ( Table 1 ),
suggesting that these mutants have reduced affinity for the inhibitor.
Labeling characteristics of intra-and extracellular cysteines.
The fluorophore fluorescein maleimide reacts with cysteine residues in polar environments, but not with cysteines in nonpolar environments (20) . Cysteines in putative transmembrane domains were found to be non-accessible to fluorescein maleimide, whereas cysteines in polar loop regions are readily labeled (e.g. (Fig. 3A) . Even when fluorescein-maleimide labeling experiments with mutants S65C and S287C were repeated at higher temperatures and prolonged incubation times, no modification was observed (Fig. 3B) . However, when these cysteine mutants were solubilized from inside-out membrane vesicles using the detergent ndodecyl-β-D-maltoside, they were readily labeled by fluorescein maleimide (Fig. 3C) . 
Labeling characteristics of cysteines located in the predicted membrane domain
Using inside-out membrane vesicles, the accessibility of the single cysteine mutants in the region of TMS 6 to fluorescein maleimide was tested. Surprisingly, several of these cysteines were labeled by fluorescein maleimide (Fig. 4) . Although these residues are predicted to reside within the membrane domain of LmrA, the accessibility of these residues for fluorescein maleimide indicates a location in the protein structure, which is well exposed to the aqueous environment. The cysteine residues in the mutants that are not labeled are either buried in the protein structure or exposed to the lipid environment. The periodicity of fluorescein maleimide accessibility (Fig. 4 ) strongly suggests that the region between Leu-291
and Val-308 spans the membrane as an α-helix, which has one face of the helix accessible to an aqueous cavity. Indeed, when this region is modeled as an α-helix, the solvent accessible residues cluster on one face of the helix (Fig. 5) . The poorly expressed and transport inactive mutants also cluster on this face of the helix (Fig. 5) .
From the labeling pattern of the cysteines located in the external and internal loops of LmrA (Fig. 3A) , it appeared that fluorescein maleimide does not cross the membrane of inside-out vesicles. To confirm that the cysteine residues in helix 6 are accessible from the outside of inside-out membrane vesicles, the single cysteines were, prior to labeling with fluorescein maleimide, incubated with the charged and reportedly membrane-impermeable MTSET (24) . In all cases, labeling by fluorescein maleimide was blocked by MTSET (Fig. 6 ),
indicating that the cysteines in helix 6 are indeed accessible from the outside (corresponding to the cytoplasmic site of whole cells) of inside-out vesicles.
The fluorescein maleimide-reactive positions periodically align the full-length of TMS 6, suggesting that one side of this transmembrane helix faces a water-filled transmembrane chamber. Other parts of transmembrane regions of LmrA are also needed to compose such a water-filled chamber. To obtain information about potential other components of this chamber the accessibility for fluorescein maleimide of single cysteines introduced at positions of the membrane-embedded aromatic residues was tested. At least one single cysteine residue present in each TMS could be labeled by fluorescein maleimide (Fig. 7) , and this labeling was prevented by pre-incubation with MTSET (data not shown). These results suggest that several transmembrane segments of LmrA are involved in the formation of an aqueous chamber in the membrane that is accessible from the cytoplasm.
Effect of thiol-reagents on transport activity
The effect of cysteine modification on Hoechst 33342 transport was determined in inside-out membrane vesicles prepared from cells expressing the single cysteine mutants.
Two small thiol-reagents were used: NEM and MTSEA, which are both membrane The single cysteine mutants that were not affected by NEM either tolerated modification or could not be modified at all because they were not accessible. To distinguish between these two possibilities, the effect of NEM pre-treatment on labeling of the mutant proteins with fluorescein maleimide was determined. For all single cysteine mutants tested, pre-treatment with NEM prevents labeling by fluorescein maleimide, showing that these cysteine residues are accessible for NEM (Fig. 8, data not shown) . The NEM-accessibility of mutants that could not be modified by fluorescein maleimide was not determined.
DISCUSSION
LmrA is an ABC multidrug transporter that mediates the extrusion of amphiphilic compounds from the inner leaflet of the membrane into the external water fase. The major physicochemical characteristics of the substrates of LmrA are: hydrophobic ring structure, presence of a basic amino group, and a high potency to partition within membranes. It is therefore most likely that the translocation path of LmrA is lined with non-polar residues (possibly aromatic side chains), in contrast to the translocation path of proteins that transport membrane-impermeable hydrophilic substrates. In this work we used a cysteine scanning mutagenesis approach in combination with thiol-modification techniques to obtain structural information about LmrA and to determine whether residues in the membrane-embedded domain of this transporter for hydrophobic molecules are accessible to the solvent.
To our surprise, only a very small number of residues appear to be essential to LmrA function. A set of 41 single cysteine mutants was constructed and nearly all mutants (37)
showed a measurable transport activity. Only one protein of the inactive cysteine mutants (L301C) is not detectable at measurable levels, while two proteins (M299C and N300C) are poorly expressed, and one protein (F37C) is highly susceptible to proteinase activity. A role of these residues in catalytic activity is thus not evident. It is possible that they play a role in folding, insertion, or stability of the protein. It is noteworthy that cysteine replacements of residues in the middle of TMS 6 resulted in a drastic decrease in transport activity while replacements of membrane-embedded aromatic residues or residues in loop regions hardly affected the activity. Partially this might be explained by the reduced expression levels of these mutant proteins, but it also may reflect the role of TMS 6 in substrate binding. The finding that most residues of multidrug transporters can be replaced without serious impairment of function has previously been described and discussed for P-glycoprotein (25) and the secondary multidrug transporter EmrE from E. coli (26) . Importantly, it has also been observed that several single amino acid replacements in P-glycoprotein resulted into an altered substrate profile (25) . Therefore, the role of the mutated residues in LmrA needs to be studied further by a more detailed characterization of the substrate specificity of the mutant proteins.
In our studies, mutagenesis of TMS 6 has generated proteins with modified specificity to at least one of the modulators of LmrA, which is most obvious for mutant A309C. This mutant displayed high Hoechst 33342 transport activity, but, in contrast to the wild-type protein, Hoechst 33342 transport was poorly inhibited by verapamil, suggesting that this mutant had lost the ability to bind verapamil with high affinity. Mutants L298C, G303C, and T307C also seem to be affected in their ability to bind verapamil. Loo and Clarke (27) Further mutagenesis studies, which could be guided by the presumed anologies to the verapamil binding contacts in P-glycoprotein, are required to define all residues involved in binding of verapamil by LmrA.
In previous studies, fluorescein maleimide, which at neutral pH is a di-anion and membrane-impermeable, proved to be a useful fluorophore to determine the membrane topology of integral membrane proteins by modification of engineered cysteines (21, 22, 23) .
It was found that this thiol-reagent does not react with cysteines in the lipidic membrane According to the hydrophobic vacuum cleaner mechanism proposed for LmrA (10) , the intracellular milieu is the inner leaflet of the membrane bilayer, whereas the extracellular milieu is the aqueous phase. Substrate translocation from the lipid phase to the aqueous phase could involve entering of the substrate in a lipid-filled chamber from the inner leaflet of the membrane bilayer, opening of the chamber to the extracellular milieu by an ATP-hydrolysis induced conformation change of the transporter and release of the substrate into the extracellular aqueous phase. However, the results presented above indicate the presence of a water-filled chamber within the LmrA transporter, which under non-energized conditions is exposed to the cytosol. This water-filled chamber is formed by one side of TMS 6 with contributions from other TMSs. The presence of this cytoplasmic exposed, water-filled chamber within the transporter implies that hydrophobic substrates are excreted from the membrane into the aqueous phase within the chamber, consistent with a vacuum cleaner mechanism, before being released into the extracellular aqueous phase. Significant conformational changes in LmrA upon hydrolysis of ATP have been detected by ATR-FTIR spectroscopy (28, 29) . These conformational changes might lead to an opening of the waterfilled chamber to the external surface as has been indicated by recent structural studies of a functional homolog of LmrA, P-glycoprotein (30) . Projection structures of P-glycoprotein showed that the TMDs of this protein can form a chamber within the membrane that opens to the extracellular milieu. Apparently, P-glycoprotein was trapped in the crystals in a conformation distinct from the one analyzed here for LmrA. Thus, most likely the lipophilic substrate is released into an externally exposed, water-filled chamber, formed as a result of ATP hydrolysis-induced conformational changes, from which it exits the cell.
Taken the currently available data together, it appears that the TMDs of ABC multidrug (-like) transporters form a chamber within the membrane that alternates between at least two different conformations; one with the chamber exposed to the intracellular environment, and one in which the chamber has an opening to the extracellular environment.
Our experimental results presented here and previous proton-deteurium exchange studies combined with ATR-FTIR spectroscopy of LmrA (28) indicate that the chamber in these proteins is water-filled rather than lipid-filled. L292C  G293C  M294C  M295C  M296C  Y297C  L298C  M299C  N300C  L301C  I302C  G303C  V304C  V305C  P306C  T307C  V308C  A309C  T310C  F311C  F312C   30  31  30  37  78  16  40  35  0  0  0 (i)  32  28  29  28  29  20  21  87  78  65 with 1 mM NEM. After purification, 5 µg of protein was subjected to SDS-PAGE (lower panels). Labeled proteins were visualized with a Lumi-imager (upper panels).
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